Page last updated: 2024-11-05

triamterene and Carcinoma

triamterene has been researched along with Carcinoma in 2 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roberts, D1
Hall, TC1
Yamada, S1
Reynolds, TB1

Trials

1 trial available for triamterene and Carcinoma

ArticleYear
Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Gastroenterology, 1970, Volume: 59, Issue:6

    Topics: Acid-Base Equilibrium; Amidines; Ascites; Autopsy; Carcinoma; Diuretics; Ethacrynic Acid; Humans; Hy

1970

Other Studies

1 other study available for triamterene and Carcinoma

ArticleYear
Triamterene-induced elevation of dihydrofolate reductase activity in human leukocytes.
    Biochemical pharmacology, 1968, Volume: 17, Issue:3

    Topics: Carcinoma; Carcinoma, Squamous Cell; Enzyme Induction; Head and Neck Neoplasms; Humans; Leukocytes;

1968